508 related articles for article (PubMed ID: 24517927)
21. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.
Kim YH; Hu H; Guevara-Gallardo S; Lam MT; Fong SY; Wang RA
Development; 2008 Nov; 135(22):3755-64. PubMed ID: 18952909
[TBL] [Abstract][Full Text] [Related]
22. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
[TBL] [Abstract][Full Text] [Related]
23. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
24. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
Kaenel P; Schwab C; Mülchi K; Wotzkow C; Andres AC
Int J Oncol; 2011 Jan; 38(1):151-60. PubMed ID: 21109936
[TBL] [Abstract][Full Text] [Related]
25. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
Das A; Shergill U; Thakur L; Sinha S; Urrutia R; Mukhopadhyay D; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G908-15. PubMed ID: 20338920
[TBL] [Abstract][Full Text] [Related]
26. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
27. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
Huang X; Yamada Y; Kidoya H; Naito H; Nagahama Y; Kong L; Katoh SY; Li WL; Ueno M; Takakura N
Cancer Res; 2007 Oct; 67(20):9800-8. PubMed ID: 17942910
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical study of vascular endothelial growth factor, relative receptors and ligands in vascular endothelial cells of cerebral arteriovenous malformation].
Li J; Gao Y; Zhao M
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):675-8. PubMed ID: 11769600
[TBL] [Abstract][Full Text] [Related]
29. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
30. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study in dural arteriovenous fistula and possible role of ephrin-B2 for development of dural arteriovenous fistula.
Tirakotai W; Bian LG; Bertalanffy H; Siegfried B; Sure U
Chin Med J (Engl); 2004 Dec; 117(12):1815-20. PubMed ID: 15603710
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
[TBL] [Abstract][Full Text] [Related]
33. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
Luxey M; Laussu J; Jungas T; Davy A
Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541
[TBL] [Abstract][Full Text] [Related]
34. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
Davies MH; Stempel AJ; Hubert KE; Powers MR
Dev Dyn; 2010 Jun; 239(6):1695-707. PubMed ID: 20503366
[TBL] [Abstract][Full Text] [Related]
35. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
[TBL] [Abstract][Full Text] [Related]
37. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
[TBL] [Abstract][Full Text] [Related]
38. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
Shin D; Garcia-Cardena G; Hayashi S; Gerety S; Asahara T; Stavrakis G; Isner J; Folkman J; Gimbrone MA; Anderson DJ
Dev Biol; 2001 Feb; 230(2):139-50. PubMed ID: 11161568
[TBL] [Abstract][Full Text] [Related]
39. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations.
Ng I; Tan WL; Ng PY; Lim J
J Clin Neurosci; 2005 Sep; 12(7):794-9. PubMed ID: 16165361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
